Guava Leaf Extract Attenuates Insulin Resistance via the PI3K/Akt Signaling Pathway in a Type 2 Diabetic Mouse Model

References

• Vinayagam R, Xiao J, Xu B. An insight into anti-diabetic properties of dietary phytochemicals. Phytochem Rev. 2017;16(3):535–553. doi:10.1007/s11101-017-9496-2
   Web of Science ®Google Scholar
• Hogger P, Xiao JB. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem. 2015;22(1):23–38. doi:10.2174/0929867321666140706130807
   PubMedGoogle Scholar
• Manning BD, Toker A. AKT/PKB Signaling: navigating the Network. Cell. 2017;169(3):381–405. doi:10.1016/j.cell.2017.04.001
   PubMed Web of Science ®Google Scholar
• Saini KS, Loi S, De Azambuja E, et al. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat Rev. 2013;39(8):935–946. doi:10.1016/j.ctrv.2013.03.009
   PubMed Web of Science ®Google Scholar
• Carvalho E, Rondinone C, Smith U. Insulin resistance in fat cells from obese Zucker rats - Evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem. 2000;206:7–16. doi:10.1023/A:1007009723616
   PubMedGoogle Scholar
• Chan SMH, Ye JM. Strategies for the discovery and development of anti-diabetic drugs from the natural products of traditional medicines. J Pharm Pharm Sci. 2013;16(2):207–216. doi:10.18433/J3T60G
   PubMedGoogle Scholar
• Hu X, Wang M, Bei W, et al. The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome. J Transl Med. 2014;12:47. doi:10.1186/1479-5876-12-47
   PubMedGoogle Scholar
• Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf. 2013;12(2):153–175. doi:10.1517/14740338.2013.752813
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Day C. The future of new drugs for diabetes management. Diabetes Res Clin Pract. 2019;155:107785. doi:10.1016/j.diabres.2019.107785
   PubMed Web of Science ®Google Scholar
• Vieira R, Souto SB, Sanchez-Lopez E, et al. Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome-review of classical and new compounds: part-I. Pharmaceuticals (Basel). 2019;12:152. doi:10.3390/ph12040152
   PubMedGoogle Scholar
• Soman S, Rauf AA, Indira M, et al. Antioxidant and antiglycative potential of ethyl acetate fraction of psidium guajavaleaf extract in streptozotocin-induced diabetic Rats. Plant Foods Hum Nutr. 2010;65(4):386–391. doi:10.1007/s11130-010-0198-9
   PubMedGoogle Scholar
• Shen SC, Cheng FC, Wu NJ. Effect of guava (Psidium guajava Linn.) leaf soluble solids on glucose metabolism in type 2 diabetic rats. Phytother Res. 2008;22(11):1458–1464. doi:10.1002/ptr.2476
   PubMedGoogle Scholar
• Gutiérrez RM, Mitchell S, Solis RV. Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 2008;117(1):0–27.
   Google Scholar
• Cheng FC, Shen SC, Wu JS. Effect of guava (Psidium guajava L.) leaf extract on glucose uptake in rat hepatocytes. J Food Sci. 2009;74(5):H132–H138. doi:10.1111/j.1750-3841.2009.01149.x
   PubMedGoogle Scholar
• Alessandro B, Federica C, Geltrude M, et al. Insulin signaling in insulin resistance states and cancer: a modeling analysis. PLoS One. 2016;11(5):e0154415. doi:10.1371/journal.pone.0154415
   PubMedGoogle Scholar
• Du Y, Wei T. Inputs and outputs of insulin receptor. Protein Cell. 2014;5(3):203–213. doi:10.1007/s13238-014-0030-7
   PubMedGoogle Scholar
• Dokken BB, Sloniger JA, Henriksen EJ. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab. 2005;288(6):1188–1194. doi:10.1152/ajpendo.00547.2004
   Google Scholar
• Liu LZ, Cheung SCK, Lan LL, et al. Berberine modulates insulin signaling transduction in insulin-resistant cells. Mol Cell Endocrinol. 2010;317(1–2):148–153. doi:10.1016/j.mce.2009.12.027
   PubMed Web of Science ®Google Scholar
• Attawish A, Chavalittumrong P, Rugsamon P, et al. Toxicity study of Psidium guajava Linn. leaves. Bull Dep Med Sci. 2013.
   Google Scholar
• Mathur R, Shagun D, Velpandian T, et al. Psidium guajavaLinn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: an experimental study. Pharmacognosy Res. 2015;7(2):166–175. doi:10.4103/0974-8490.151459
   PubMedGoogle Scholar
• Wang L, Liu Y, Luo Y, et al. Quickly screening for potential α-glucosidase inhibitors from guava leaves tea by bioaffinity ultrafiltration coupled with HPLC-ESI-TOF/MS method. J Agr Food Chem. 2018;66(6):acs.jafc.7b05280.
   Google Scholar
• Vinayagam R, Jayachandran M, Chung S, et al. Guava leaf inhibits hepatic gluconeogenesis and increases glycogen synthesis via AMPK/ACC signaling pathways in streptozotocin-induced diabetic rats. Biomed Pharmacother. 2018;103(2018). doi:10.1016/j.biopha.2018.04.127
   PubMedGoogle Scholar
• Liu CW, Wang YC, Hsieh CC, et al. Guava (Psidium guajava Linn.) leaf extract promotes glucose uptake and glycogen accumulation by modulating the insulin signaling pathway in high-glucose-induced insulin-resistant mouse FL83B cells. Proc Biochem. 2015;50(7):1128–1135. doi:10.1016/j.procbio.2015.03.022
   Web of Science ®Google Scholar
• Eidenberger T, Selg M, Krennhuber K. Inhibition of dipeptidyl peptidase activity by flavonol glycosides of guava (Psidium guajava L.): a key to the beneficial effects of guava in type II diabetes mellitus. Fitoterapia. 2013;89(Complete):74–79. doi:10.1016/j.fitote.2013.05.015
   PubMedGoogle Scholar